Live feed
Filing
SC 13D
SC 13D0001415889-15-001636·Damaj Bassam
Schedule 13D ownership disclosure
INNOVUS PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45778V106
Event date: 2011-12-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,953,346
- Percent of class
- 36.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-15-001636
- Form type
- SC 13D
- Filer
- Damaj Bassam
- CIK
- CIK 1478733
- Filed
- May 13, 2015
- Reporting period
- Dec 07, 2011
- Description
- Schedule 13D beneficial ownership